GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (OTCPK:SRBCF) » Definitions » Net Change in Cash

Sirona Biochem (Sirona Biochem) Net Change in Cash : $-0.04 Mil (TTM As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sirona Biochem Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Sirona Biochem's Net Change in Cash for the three months ended in Jan. 2024 was $-0.34 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.04 Mil.

Sirona Biochem Net Change in Cash Historical Data

The historical data trend for Sirona Biochem's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Net Change in Cash Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.58 -1.66 -0.61 -0.26 0.11

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.21 0.57 -0.45 0.19 -0.34

Sirona Biochem Net Change in Cash Calculation

Sirona Biochem's Net Change in Cash for the fiscal year that ended in Oct. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-1.282+0+1.276+0.115
=0.11

Sirona Biochem's Net Change in Cash for the quarter that ended in Jan. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.405+0+0.063+-0.001
=-0.34

Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sirona Biochem Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (Sirona Biochem) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (OTCPK:SRBCF) » Definitions » Net Change in Cash
Comparable Companies
TSX:RVX TSX:ATE XCNQ:BETR TSX:AEZS XCNQ:ASEP XCNQ:PREV TSXV:KNE XCNQ:MDMA XCNQ:PHRM XCNQ:BIOV OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
ZSB:Germany SBM:Canada
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Website
https://www.sironabiochem.com
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (Sirona Biochem) Headlines

From GuruFocus

Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics

By GuruFocusNews GuruFocusNews • 07-03-2022

Sirona Biochem Initiates Significant Corporate Changes

By GuruFocusNews GuruFocusNews • 07-05-2022

Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension

By GlobeNewswire GlobeNewswire • 05-15-2018

Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares

By GlobeNewswire • 10-20-2023

Sirona Biochem Initiates Significant Corporate Changes

By GuruFocusNews GuruFocusNews • 06-15-2022

Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics

By PurpleRose PurpleRose • 07-13-2022

Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics

By GuruFocusNews GuruFocusNews • 06-13-2022

Sirona Biochem Initiates Significant Corporate Changes

By GuruFocusNews GuruFocusNews • 06-25-2022

Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics

By GuruFocusNews GuruFocusNews • 06-23-2022

Sirona Biochem Initiates Significant Corporate Changes

By PurpleRose PurpleRose • 07-15-2022